News
With its move to MIT’s Volpe Center in Kendall Square, the drugmaker is consolidating its local footprint from three buildings to one.
1 “Biogen has been a foundational presence in the Massachusetts life science ecosystem for close to half a century, and we are thrilled to see them begin a new era in our state,” said Maura Healey, ...
A new survey by Careerminds, a global outplacement and career development firm, found that benefits like retirement ...
Massachusetts governor Maura T. Healey ’92 called Biogen a “foundational presence” in the Massachusetts life sciences landscape. “This milestone is an example of why Massachusetts remains ...
Biogen Inc. plans to move its headquarters into a 16-story Kendall Square tower to be developed by MIT and BioMed Realty, which would consolidate the biotech giant's once-sprawling operations in ...
Massachusetts-based Biogen will pay Forward $1.25 billion upfront, and under a licence agreement may pay future royalties from Tecfidera dependent on ongoing patent cases in US and EU.
The company said the move is part of a multi-year real estate consolidation plan in Massachusetts. Biogen said it has signed a 15-year lease for ~580K sq. ft. of office and research and ...
Biogen signs lease for Kendall Common as part of multi-year real estate optimization plan to modernize its facilities and consolidate its Massachusetts real estate footprint New building will be ...
Biogen, Inc. is a biopharmaceutical company ... and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.
Massachusetts-based Biogen also has exclusive rights to nominate up to nine additional undisclosed targets over a target selection period of five years. Sangamo will perform early research ...
Biogen signs lease for Kendall Common as part of multi-year real estate optimization plan to modernize its facilities and consolidate its Massachusetts real estate footprint; New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results